Arkolith/Insider Trading/CORT/Form 4

Robb Gary Charles

Chief Business OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jun 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Tax withholding(F)358$70.44$25K26K
Jun 1, 2026Grant(A)776$70.44$55K25K
Jun 1, 2026Grant(A)776—$026K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-256002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML